par Bonnet, Christophe;Lejeune, Marie;Van Kemseke, Catherine;Bron, Dominique ;Beguin, Yves
Référence Revue médicale suisse, 11, 483, page (1549-1556)
Publication Publié, 2015-08
Article révisé par les pairs
Résumé : Marginal zone lymphomas (MZL) encompass three sub-types : MALT (Mucosae Associated Lymphoïd Tissue) MZL, nodal MZL and splenic MZL. Immunophenotyping is essential for accurate diagnosis. Helicobacter Pylori is frequently associated with gastric localizations and its eradication can be sufficient for cure. Treatment of nodal MZL is similar to that of follicular lymphoma. Eradication of hepatitis C virus, frequently associated with splenic MZL development, can be sufficient. Without HCV infection, splenectomy constitutes first line therapy. As other indolent lymphomas, disseminated MZL are incurable and treatment should be started only in symptomatic patients.